BIO-TECHNE CORPORATION

(TECH)
  Reporte
Tiempo real estimado Cboe BZX  -  21:03 18/08/2022
360.95 USD   -0.50%
16/08BIO-TECHNE CORPORATION : Wells Fargo Securities reitera su recomendación de venta
MM
12/08VENTA DE INFORMACIÓN PRIVILEGIADA : Bio-techne
MT
12/08BIO-TECHNE CORPORATION : Desprendimiento de dividendo
FA
ResumenCotizacionesGráficosNoticiasRatingsAgendaEmpresaFinanzasConsensoRevisionesDerivados 
ResumenTodasRecomendaciones analistasOtros idiomasComunicadosPubls. oficialesNoticias del sector
Noticias en otros idiomas sobre BIO-TECHNE CORPORATION
13:01Bio-techne announces release of quantist luminex® data analysis software
12/08INSIDER SELL : Bio-techne
10/08AcouSort significantly strengthens its commercial capabilities with the recruitments of..
05/08Another case of good news is bad news
05/08BIO TECHNE : ANNOUNCES CEO TRANSITION PLAN - Form 8-K
05/08BIO-TECHNE CORP : Change in Directors or Principal Officers, Financial Statements and Exhi..
04/08TRANSCRIPT : Bio-Techne Corporation, Q4 2022 Earnings Call, Aug 04, 2022
04/08Bio-Techne Fiscal Q4 Adjusted Earnings, Sales Rise; CEO Chuck Kummeth to Retire in 2024
04/08Earnings Flash (TECH) BIO-TECHNE CORPORATION Reports Q4 Revenue $288.2M
04/08Earnings Flash (TECH) BIO-TECHNE CORPORATION Reports Q4 EPS $2.05
04/08BIO-TECHNE CORP : Results of Operations and Financial Condition, Other Events, Financial S..
04/08Bio-techne releases fourth quarter fiscal 2022 results
04/08Bio-techne announces ceo transition plan
04/08Bio-techne declares dividend
04/08Bio-Techne Corporation Reports Earnings Results for the Full Year Ended June 30, 2022
04/08Bio-Techne Corporation Reports Earnings Results for the Fourth Quarter Ended June 30, 2..
04/08Bio-Techne Corporation Announces Dividend for the Quarter Ended June 30, 2022, Payable ..
04/08Bio-Techne Corporation Announces CEO Transition Plan
28/07Bio-techne announces licensing agreement and partnership with university of dundee
28/07Bio-Techne Corporation Announces Licensing Agreement
14/07Bio-techne to host conference call on august 4, 2022, to announce fourth quarter 2022 f..
12/07BIO-TECHNE LAUNCHES NEW TURBO CE-SDS™ CARTRIDGE, ACCELERATING PROTEIN PURITY ANAL..
12/07Bio-Techne Launches New Turbo CE-SDS ™ Cartridge, Accelerating Protein Purity Anal..
06/07Bio-Techne Announces Launch of the CE-IVD RNAscope ISH Probe High Risk HPV Assay for He..
05/07Bio-techne announces completion of namocell acquisition
05/07Bio-Techne Corporation completed the acquisition of Namocell, Inc.
24/06BIO-TECHNE CORPORATION(NASDAQGS : TECH) dropped from Russell 1000 Growth-Defensive Index
24/06BIO-TECHNE CORPORATION(NASDAQGS : TECH) dropped from Russell 1000 Defensive Index
22/06Bio-Techne to Acquire Namocell for Undisclosed Terms
22/06Bio-techne to acquire namocell
22/06Bio-Techne Corporation reached an agreement to acquire Namocell, Inc.
09/06INSIDER SELL : Bio-techne
08/06TRANSCRIPT : Bio-Techne Corporation Presents at 2022 Jefferies Global Healthcare Conferenc..
26/05Bio-Techne Celebrates 40,000 Unique RNAscope™ in situ Hybridization Probes, Targe..
25/05Global study demonstrates ice3 and maurice capillary isoelectric focusing comparability..
25/05Bio-Techne Corporation Announces the Publication of A Global Study in the Journal of El..
19/05Bio-techne to present at the jefferies healthcare conference
12/05Bio-Techne Unit, Nonagen Bioscience Sign Manufacturing Deal for Oncuria Bladder Cancer ..
12/05Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Onc..
12/05Bio-Techne Corporation and Nonagen Bioscience Announce Exclusive Supply Agreement for N..
11/05TRANSCRIPT : Bio-Techne Corporation Presents at Bank of America 2022 Healthcare Conference..
11/05INSIDER BUY : Bio-Techne
09/05BIO-TECHNE CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL (form 10-Q)
09/05Tranche Update on Bio-Techne Corporation's Equity Buyback Plan announced on November 14..
09/05Tranche Update on Bio-Techne Corporation's Equity Buyback Plan announced on February 1,..
04/05TRANSCRIPT : Bio-Techne Corporation, Q3 2022 Earnings Call, May 04, 2022
04/05Bio-Techne Fiscal Q3 Adjusted Earnings, Sales Rise; Quarterly Dividend Retained at $0.3..
04/05BIO-TECHNE CORP : Results of Operations and Financial Condition, Other Events, Financial S..
04/05Bio-Techne Corporation Reports Earnings Results for the Third Quarter and Nine Months E..
04/05Earnings Flash (TECH) BIO-TECHNE CORPORATION Posts Q3 Revenue $290.4M
04/05Earnings Flash (TECH) BIO-TECHNE CORPORATION Reports Q3 EPS $2.14
04/05Bio-techne releases third quarter fiscal 2022 results
04/05Bio-techne declares dividend
04/05Bio-Techne Corporation Declares Quarterly Dividend for the Quarter Ended March 31, 2022..
02/05BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
27/04BIO-TECHNE CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (form 8-..
26/04Bio-techne included on the forbes best employers for diversity 2022 list
13/04Bio-techne to host conference call on may 4, 2022, to announce third quarter 2022 finan..
12/04Bio-Techne and Cygnus Technologies, Part of Maravai Lifesciences, Introduces New Simple..
07/04BIO TECHNE : Corporate Presentation – March 2022
23/03Bio-Techne Seeks Mergers and Acquisitions
23/03TRANSCRIPT : Bio-Techne Corporation Presents at 2022 KeyBanc Capital Markets Life Sciences..
17/03Bio-techne to present at the keybanc life sciences & medtech investor forum
16/03TRANSCRIPT : Bio-Techne Corporation Presents at Barclays Global Healthcare Conference 2022..
09/03Bio-techne to present at the barclays global healthcare conference
07/03TRANSCRIPT : Bio-Techne Corporation Presents at 42nd Annual Cowen Health Care Conference, ..
28/02Bio-techne to present at the cowen 42nd annual health care conference
24/02TRANSCRIPT : Bio-Techne Corporation Presents at Citi’s 2022 Virtual Healthcare Confer..
22/02Bio-techne to present at the citi 2022 virtual healthcare conference
22/02Bio-Techne, Thermo Fisher Scientific in Agreement to Develop, Commercialize Kidney Tran..
22/02BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCI..
17/02TRANSCRIPT : Bio-Techne Corporation Presents at 11th SVB Leerink Annual Global Healthcare ..
11/02BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
07/02BIO-TECHNE CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL (form 10-Q)
07/02Tranche Update on Bio-Techne Corporation's Equity Buyback Plan announced on November 14..
1  2  3  4  5  6  7  8  9  10Siguiente
Próximo evento sobre BIO-TECHNE CORPORATION